Skip to main content

RV Enlargement on Echocardiography: ASE 2025 Grading, Causes and Clinical Interpretation

RV Enlargement on Echocardiography: ASE 2025 Grading, Causes and Clinical Interpretation

How to measure RV on echo


Right ventricular enlargement is an important echocardiographic finding that may reflect pressure overload, volume overload or intrinsic myocardial disease. However, RV dilatation is not a diagnosis by itself, and its significance depends on the underlying clinical condition and associated echocardiographic abnormalities.

In Part 1, we reviewed the updated 2025 American Society of Echocardiography (ASE) normal reference values and measurement techniques for RV basal, mid-ventricular and longitudinal dimensions.

In this second part, we discuss the grading of RV enlargement, its clinical interpretation, associated echocardiographic parameters, common measurement errors and practical reporting.

1. What Is Right Ventricular Enlargement?

Right ventricular enlargement refers to an increase in RV cavity dimensions beyond the expected reference range. It may involve the basal region, mid-ventricular cavity, longitudinal dimension or the entire chamber.

The right ventricle has complex geometry, so a single linear measurement may not adequately represent its total size. An integrated assessment using multiple dimensions and, when available, three-dimensional RV volumes provides a more complete evaluation.

Clinical Pearl

RV enlargement and RV systolic dysfunction are different findings. A dilated RV may have preserved systolic function, while a normal-sized RV may demonstrate impaired contraction.

2. Grading RV Enlargement According to ASE 2025

The 2025 ASE recommendations provide graded thresholds for selected RV linear dimensions.

Measurement Mild Moderate Severe
Basal RV diameter 4.1–4.4 cm >4.4–4.9 cm >4.9 cm
Mid-ventricular diameter 3.5–3.8 cm >3.8–4.2 cm >4.2 cm
Longitudinal diameter 8.2–8.9 cm >8.9–9.6 cm >9.6 cm

These thresholds describe enlargement of individual dimensions. They should not be interpreted as a complete assessment of RV chamber volume or systolic performance.

If the basal, mid-ventricular and longitudinal measurements fall into different severity categories, the overall interpretation should consider RV geometry, image quality and other structural findings rather than assigning a severity grade based on one value alone.

3. Causes of RV Enlargement

A. RV Pressure Overload

Pressure overload occurs when the right ventricle must generate higher pressures to maintain forward blood flow through the pulmonary circulation.

Important causes include:

  • Pulmonary arterial hypertension.
  • Pulmonary hypertension associated with left heart disease.
  • Chronic thromboembolic pulmonary hypertension.
  • Acute pulmonary embolism.
  • Right ventricular outflow obstruction and pulmonary stenosis.

Depending on the duration and severity of pressure overload, echocardiography may show RV hypertrophy, chamber enlargement, septal flattening and reduced systolic function.

B. RV Volume Overload

Volume overload develops when excessive blood volume enters or returns to the right ventricle.

Common causes include:

  • Significant tricuspid regurgitation.
  • Pulmonary regurgitation.
  • Atrial septal defect.
  • Other congenital left-to-right shunts.

RV volume overload may produce progressive chamber enlargement, with additional findings depending on the underlying lesion.

C. Intrinsic RV Myocardial Disease

Right ventricular enlargement may also occur in cardiomyopathies and other myocardial disorders. In these patients, chamber enlargement may be associated with regional wall-motion abnormalities or reduced global RV systolic function.

When the diagnosis remains uncertain, cardiac magnetic resonance imaging may provide additional information about RV volumes, function and myocardial characteristics.

4. How to Differentiate RV Pressure and Volume Overload

The pattern of interventricular septal flattening can provide useful information about RV loading conditions.

  • Predominantly systolic septal flattening: Often suggests RV pressure overload.
  • Predominantly diastolic septal flattening: Often suggests RV volume overload.
  • Flattening throughout the cardiac cycle: May occur with significant pressure overload or combined loading abnormalities.

These patterns are supportive findings and should not be used as the sole basis for determining the mechanism of RV enlargement.

5. Assessing RV Systolic Function

RV size and systolic function should be evaluated separately. A comprehensive assessment may include the following parameters.

Tricuspid Annular Plane Systolic Excursion (TAPSE)

TAPSE measures longitudinal systolic displacement of the lateral tricuspid annulus. It is simple and widely available but reflects primarily longitudinal motion and is influenced by loading conditions.

Tissue Doppler S′ Velocity

S′ measures systolic myocardial velocity at the lateral tricuspid annulus. Like TAPSE, it primarily reflects longitudinal RV function.

RV Fractional Area Change

RV FAC is calculated from the difference between RV end-diastolic and end-systolic areas divided by the end-diastolic area, multiplied by 100.

It provides a two-dimensional estimate of RV systolic performance but depends on accurate tracing of the RV endocardial border.

RV Free-Wall Longitudinal Strain

RV free-wall strain evaluates myocardial deformation and can detect abnormalities in longitudinal function. Interpretation should account for acquisition quality, software methodology and the applicable reference values.

Three-Dimensional RV Ejection Fraction

Three-dimensional echocardiography allows a more comprehensive assessment of RV volumes and ejection fraction without relying solely on geometric assumptions from linear dimensions.

It may be particularly helpful when RV size and function cannot be adequately characterized using conventional two-dimensional imaging.

6. Other Echocardiographic Findings to Evaluate

When RV enlargement is present, assess additional right-heart parameters to determine its likely cause and clinical significance.

  • Right atrial size: Enlargement may indicate chronic right-sided pressure or volume overload.
  • Tricuspid regurgitation: Assess severity and Doppler characteristics.
  • Estimated pulmonary artery pressure: Interpret the tricuspid regurgitation velocity and other echocardiographic findings together.
  • Inferior vena cava: Evaluate diameter and respiratory variation when estimating right atrial pressure.
  • Interventricular septum: Look for flattening or abnormal septal motion.
  • RV outflow tract and pulmonary valve: Evaluate for obstruction, regurgitation or structural abnormalities when indicated.

7. Common Measurement Errors

Inaccurate RV measurements can lead to inappropriate classification of chamber size. Common pitfalls include:

  • Using a conventional apical four-chamber view instead of an RV-focused view.
  • Foreshortening the RV apex.
  • Measuring during systole rather than end-diastole.
  • Incorrect caliper placement at the myocardial or pericardial borders.
  • Using anatomical landmarks that differ from the updated ASE measurement definitions.
  • Changing imaging planes between serial examinations.
  • Interpreting isolated measurements without considering overall RV geometry.
Practical Tip

When a measured RV dimension is unexpectedly abnormal, review the imaging plane, end-diastolic timing and anatomical landmarks before concluding that RV enlargement is present. Consistent technique is especially important when comparing serial echocardiograms.

8. Practical Echocardiography Reporting

A useful RV report should describe chamber size, systolic function and relevant associated abnormalities.

Illustrative Reporting Example

The right ventricle is enlarged, with a basal diameter of 4.6 cm, mid-ventricular diameter of 3.9 cm and longitudinal diameter of 8.7 cm in the RV-focused apical four-chamber view. These dimensions exceed the 2025 ASE adult reference limits. RV systolic function should be reported separately using the available quantitative and qualitative parameters. Associated right-heart findings should be documented.

Actual reporting should reflect the patient's measurements, imaging quality and complete clinical context.

9. Frequently Asked Questions

What is considered RV enlargement on echocardiography?

RV enlargement is suggested when standardized dimensions exceed the applicable reference limits. According to the 2025 ASE recommendations, the adult reference limits are less than 4.1 cm for basal diameter, less than 3.5 cm for mid-ventricular diameter and less than 8.2 cm for longitudinal diameter.

Can RV enlargement occur with normal systolic function?

Yes. RV enlargement can occur with preserved systolic function, particularly in certain volume-overload conditions.

Does RV dilatation confirm pulmonary hypertension?

No. RV enlargement is nonspecific and may result from several conditions. Pulmonary hypertension assessment requires integration of multiple clinical and echocardiographic findings, with invasive haemodynamic confirmation when indicated.

Which measurement is most useful for detecting RV enlargement?

Basal RV diameter is an important and widely used measurement, but no single dimension adequately describes the entire RV. The best assessment integrates multiple dimensions and other structural findings.

What should be done when RV measurements are discordant?

Review image acquisition and measurement technique, assess overall RV geometry, and consider additional quantitative methods such as three-dimensional echocardiography or cardiac magnetic resonance imaging when clinically appropriate.

Conclusion

RV enlargement is an important structural finding with several possible causes. The 2025 ASE recommendations provide updated reference limits and standardized measurement techniques that improve the consistency of RV assessment.

Grading of RV enlargement should be based on correctly acquired measurements and interpreted alongside RV systolic function, right atrial size, valvular abnormalities, pulmonary pressure estimates and clinical context.

A comprehensive, multiparametric approach is essential for accurate diagnosis and meaningful echocardiographic reporting.

References

  1. Mukherjee M, Rudski LG, Addetia K, et al. Guidelines for the Echocardiographic Assessment of the Right Heart in Adults and Special Considerations in Pulmonary Hypertension: Recommendations from the American Society of Echocardiography. J Am Soc Echocardiogr. 2025;38(3):141–186. Read guideline.
  2. Zaidi A, Oxborough D, Augustine DX, et al. Echocardiographic assessment of the right heart in adults: a practical guideline from the British Society of Echocardiography. Echo Research and Practice. 2020;7(1):G19–G41. Read guideline.

drmusmanjaved.com

Comments

Popular posts from this blog

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...

2025 AHA/ACC Hypertension Guidelines Key points

  2025 AHA/ACC Hypertension Guidelines Explained: A Clear Summary for Clinicians and Students Hypertension remains one of the most significant contributors to cardiovascular morbidity and mortality worldwide. With continual refinement of evidence and risk-based strategies, the 2025 AHA/ACC Hypertension Guidelines bring an updated, practical approach that clinicians can use in daily practice. To make learning easier, I’ve created a clean and modern infographic summarizing all major recommendations. You can download it below and use it for study, teaching, or clinical reference. Download Infographic (PNG): 2025 Hypertension Guideline Infographic This post breaks down the key points from the guidelines and complements the infographic for a complete understanding. --- BP Categories: Understanding the Updated Thresholds The guidelines maintain the well-established classification of blood pressure: Normal: <120 / <80 Elevated: 120–129 / <80 Stage 1 Hypertension: 130–139 and/or 8...